Latest by George E. Burgess

New Experimental Drug Integrase Inhibitor (MK-0518)

For the last six years, treatment has driven the AIDS agenda. Just this past summer, the Food and Drug Administration (FDA) approved Prezista, a new Protease Inhibitor, as well as Atripla, the first once-daily single tablet regiment for adults with...

By George E. Burgess for AIDS Survival Project

Hepatitis C and Self-Management

When I arrived at my doctor's appointment in March, I was greeted with some great news: my CD4 count was going up and my viral load was undetectable. The bad news was mentioning starting hepatitis C treatment, which stopped me in my tracks. The fea...

By George E. Burgess for AIDS Survival Project